Cooley Advised Silence Therapeutics on Agreement to Be Acquired By Merck KGaA, Darmstadt, Germany for $1.3 Billion
October 20, 2026
October 20, 2026
PALO ALTO, California, Oct. 20 -- Cooley, a law firm, issued the following news release:
* * *
Cooley Advised Silence Therapeutics on Agreement to Be Acquired By Merck KGaA, Darmstadt, Germany for $1.3 Billion
October 19, 2026
Cooley advised London-headquartered, NASDAQ-listed Silence Therapeutics, a global clinical-stage biotechnology company developing precision engineered medicines using its proprietary siRNA technology, on its agreement to . . .
* * *
Cooley Advised Silence Therapeutics on Agreement to Be Acquired By Merck KGaA, Darmstadt, Germany for $1.3 Billion
October 19, 2026
Cooley advised London-headquartered, NASDAQ-listed Silence Therapeutics, a global clinical-stage biotechnology company developing precision engineered medicines using its proprietary siRNA technology, on its agreement to . . .